Instruction: Several factors affect the in-stent intimal healing process after drugeluting stents (DESs) implantation. We hope to investigate the influence of plaque characteristics on subsequent heterogeneous neointimal hyperplasia (NIH) using optical coherence tomography (OCT).
| INTRODUCTION
Due to the coming of drug-eluting stent (DES) era, target vessel revascularization has been remarkably reduced. However, very late stent failure, clinically manifesting as very late restenosis or stent thrombosis, is still an ongoing phenomenon. Inevitably, percutaneous coronary intervention (PCI) creates injury on the vessel wall to varying degrees. Neointimal growth serves as a healing mechanism may become a double-edged sword: neointimal genesis could prevent instent thrombosis while overgrowth of the intima, known as neointimal hyperplasia (NIH) may lead to in-stent restenosis (ISR). 1, 2 Besides lumen narrowing, the degree of neointimal hyperplasia after stent implantation has a positive correlation to presence of neoatherosclerosis, which is now considered as an underlying mechanism of late stent failure and as a risk factor of cardiovascular events. 3, 4 Optical coherence tomography (OCT) is a light-base imaging modality with unprecedented resolution, which enables in vivo assessment of coronary plaque microstructure, such as thin-cap fibroatheroma, thrombus, macrophage accumulation, micro-vessel, and cholesterol crystals. [5] [6] [7] Besides, OCT can effectively identify different patterns of neointimal hyperplasia as well as neoatherosclerosis, [8] [9] [10] which shows a good correlation to historic findings. [11] [12] [13] [14] OCT-based heterogeneous neointimal tissue without feature of neoatherosclerosis is also thought to be linked to poor long-term clinical prognosis. 15 Imanaka et al. have reported that the heterogeneous patterns with invisible stent strut on OCT imaging identify the presence of lipid-atherosclerotic tissue, such as foam cell accumulation and fibroatheroma, within neointima of DES. 16 So far, the formation of heterogeneous neointima is still controversial. 17, 18 Previous studies have demonstrated that it is correlated with age, level of blood lipid level, PCI for acute coronary syndrome (ACS) and history of cerebrovascular disease. 15, 19 However, predicting heterogeneous neointima with mere clinical factors seems to be inadequate. As the inner relationship between pre-procedural plaque characteristics and post-PCI neointimal hyperplasia patterns has not been fully elucidated. We hope to provide more lesion morphology-related information. Therefore, the aim of the current study was to investigate the pattern of intimal healing process using OCT, and to correlate baseline plaque micromorphology with heterogeneous neointimal hyperplasia following DES implantation.
2 | METHODS
| Study population
This was a single-center retrospective study. Between March 2014
and December 2016, we analyzed 306 patients with single-vessel de novo lesions who had no contraindication for an OCT scan and underwent this examination 1 year after DES implantation. Both pre-PCI procedural and 1-year follow-up OCT were required for this study:
pre-procedural OCT to identify the plaque characteristics while followup OCT to find out the healing patterns of endothelium after DES implantation. All procedures were performed in the Department of Cardiology of Nanjing First Hospital, Nanjing, China. These subjects with incomplete pre-procedural OCT data (n = 77), stent malapposition (n = 4) and poor-quality OCT images (n = 8) were excluded from this study. Ultimately, a total of in 217 patients were included in our final analysis.
| OCT image acquisition
Aspirin (300 mg), clopidogrel (300 mg), and heparin (100 U/kg) were administrated before any cardiac catheterization. After coronary angiography (CAG) and before PCI procedure, OCT imaging was performed to observe the lesion morphology with the frequencydomain OCT C7-XR imaging system (LightLab Imaging, Inc., Westford, MA) or ILUMIEN OPTIS (St. Jude Medical, St. Paul, MN). OCT catheter was advanced at least 10 mm distal to the target lesion for imaging and was pulled back at 20 mm/s. The non-occlusion technique by continuous intracoronary contrast medium injection was used for blood clearance. Stent implantation was followed by oral administration of dual anti-platelet agents and statin therapy at least for 1 year.
OCT examination was repeated at 1-year follow-up. All OCT data were digitally stored for further analysis.
| OCT image analysis
All OCT images were analyzed by proprietary off-line software (LightLab Imaging or St. Jude Medical) by two independent investigators who were blind to both clinical and interventional procedurerelated information of patients. If there was discordance between these observers, a consensus reading would be obtained from a third independent investigator. OCT plaque characteristics and neointimal morphology were according to previously validated criteria and related studies. 5, 12, 20, 21 Grading was performed in every 1 mm along the entire target lesion, and total macrophage grade was calculated as the summation of 0 to four grades. Mean macrophage grade was defined as total macrophage grade/target lesion length. Micro-vessel was a sharply-delineated signal-poor void and could be followed in multiple contiguous frames.
Cholesterol crystals were defined as thin, linear regions of high intensity, usually formed in the intima ( Figure 2 ).
Neointimal hyperplasia was defined as at least five consecutive crosssectional images with no less than 100 μm neointimal thickness. The patterns of in-stent neointimal hyperplasia could be divided into three categories: (i) homogeneous hyperplasia, uniform optical properties without focal variations or attenuation; (ii) heterogeneous hyperplasia,
focally changing optical properties and shows various backscattering patterns; (iii) layered hyperplasia, concentric layers with different optical properties and often with a smooth contour. 12 In-stent neointimal thickness less than 100 μm without strut malapposition were defined as neointimal coverage. In our study, typically layered neointima was barely observed. There were only six lesions showed layered feature in a few cross-sectional images while the rest of the stented segments appeared as heterogeneous. So these lesions were categorized in heterogeneous group. Finally, patients were classified into three groups according to 1-year OCT follow-up:neointima-covered group, homogeneous group and heterogeneous group ( Figure 3 ). Neoatherosclerosis was difined as instent neointima with special atherosclerotic features such as lipid, calcification, micro-vessels, or macrophages inside. 4 Cross-sectional OCT images were analyzed at 1-mm intervals along the entire target segment. At OCT follow-up, maximum, minimum, and mean neointimal thickness was calculated automatically by delicate software after manually drawing the contour of lumen and stent. Stent area and luminal cross-sectional area (CSA) was measured at the CSA with minimal lumen area (MLA) of the stented segment.
Neointimal CSA was calculated as stent CSA minus luminal CSA.
Neointimal burden (stent CSA stenosis, stent percent area obstruction) was defined as (stent CSA minus luminal CSA)/stent CSA.
| Statistical analysis
Continuous variables were expressed as mean ± standard deviations for normally distributed variables or median and interquartile range for nonparametric data according to the Kolmogorov-Smirnov or ShapiroWilk test. Normally distributed variables were compared using an unpaired Student's t-test or one-way analysis while non-normally Further more, stent length in homogeneous group is much longer than that of the other two groups (P = 0.04). However, there was no significant difference in target coronary artery, stent diameter and stent category among these three groups.
3.2 | Pre-procedural plaque characteristics and OCT imaging data at follow-up
Plaque characteristics before PCI procedure assessed by OCT are shown in OCT quantitative data about in-stent neointimal hyperplasia 1 year after stent implantation is listed in Table 4 . There was no statistically significant difference between homogeneous and heterogeneous group concerning mean intimal thickness (P = 0.21), neointimal cross-sectional area (P = 0.18), and neointimal burden (P = 0.73).
As is shown in Table 5 , using multivariate logistic regression analysis, the significant independent risk factors for heterogeneous neointimal hyperplasia were mean macrophage grade (OR: 2.26, 95%
CI: 1.12 to 4.53, P = 0.02) and initial clinical presentation of ACS (OR:
2.81, 95%CI: 1.03 to 7.72, P = 0.04).
| DISCUSSION
The principle findings of the present study were as follows: (i)
heterogeneous group tended to have more patients presented as ACS;
(ii) higher pre-procedural mean macrophage grade was found in heterogeneous group; (iii) pre-procedural TCFA detected by OCT was more frequently observed in heterogeneous group than homogeneous group; (iv) OCT-detected mean macrophage grade and clinical presentation of ACS were independent risk factors for in-stent neointimal heterogeneity.
OCT is a recently developed intravascular imaging modality which has approximately 10 times higher axial resolution (15-20 μm) than that of intravascular ultrasound (IVUS), thereby providing precise and accurate evaluation of both coronary plaque morphology and followup neointimal healing pattern. 5 Neointima shows divergent patterns in OCT images, usually featured as homogeneous, heterogeneous, and layered. Gonzalo et al. defined neointimal heterogeneity as tissue with focally changing OCT properties and various backscattering patterns. 12 Hou et al defined it as sudden change in intensity inside the region of interest. Data are presented as median (interquartile range) or n (%). TCFA, thin-cap fibroatheroma.
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Previous study done by Kim et al demonstrated that nonfatal myocardial infarction, target lesion revascularization and stent thrombosis occurred more frequently in patients with heterogeneous neointimal hyperplasia comparing to those with homogeneous and layered intima. 15 Neointimal growth following DES implantation is a complex and multifactorial process and previous studies about this have been basically limited by a lack of imaging data of baseline coronary plaque characteristics, especially high-resolute OCT data. 19, 26, 27 Investigation done by Lee et al showed neointimal proliferation is a temporal course. Both progression and regression are paralleled by qualitative changes indicating increasing instability and increasing stability. 28 Heterogeneous intima occurred 20.9% of the subjects with neointimal hyperplasia, which is in line with previous studies. A study done by Gonzalo et al has demonstrated that the presence of restenotic tissue with heterogeneous appearance was more frequent in stents implanted >12 months (33.3%) than ≤12 months (7.7%).
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Another study has reported that heterogeneous intima was more often observed in late ISR group (>1 year) compared with the early ISR group (<1 year) (89% vs 43%, P = 0.002). 29 In our study, time interval between initial OCT scan before PCI and 1-year follow-up OCT examination was not significantly different. The divergence can be caused by limited follow-up duration and small sample size. A previous study has reported that irregular protrusion post DES implantation was associated with subsequent heterogeneous neointima at 8-month follow-up. 30 Higher vessel curvature after stent implantation may also have an potential impact on the neointimal healing with a higher incidence of heterogeneous neointima. 31 Recent evidences suggested that age, blood lipid level, PCI for ACS, history of cerebrovascular disease and time interval to OCT follow-up were independent determinants for heterogeneous in-stent proliferation. 15, 19 Our findings suggested that heterogeneous group had more patients presented with ACS, which coincide with previous investigations.
A study by Hou et al. reported that micro-vessel and lipid-rich plaque were more frequently observed in neointimal with heterogeneous pattern and neointimal heterogeneity may change over time after sirolimus-eluting stent implantation. 25 De Rosa et al demonstrated that obese patients showed a greater extent of fibroatheroma (P = 0.007), TCFA (P = 0.015), and macrophage load (P = 0.043). 32 In our study, there was a trend toward a higher low-density lipoprotein cholesterol (LDL-C) level in heterogeneous group; although it was not statistically significant (P = 0.19). It to some extent indicates that high blood lipid level may be associated with large lipid burden of the plaque. Hence, the importance of lipid management must be highlighted.
Besides, we also noticed that heterogeneous group had more preprocedural TCFA on OCT imaging comparing to the neointimacovered group (P = 0.04) and homogeneous group (P = 0.02), respectively. "Vulnerable plaque" was initially introduced by Muller et al., in order to investigate which plaques are likely to rupture. 33 Thin-cap fibroatheroma (TCFA) is a type of vulnerable plaque, which is defined as a lesion with fibrous cap thickness less than 65 μm and a lipid core accounting for more than 40% of the plaque volume. 34 It is believed that TCFA is more likely to cause ACS and is an independent predictor for further clinical events. 35, 36 It has been gradually accepted that inflammation mechanism plays an crucial role both in plaque progression and vulnerability since the 1990s. 37, 38 Lipoprotein-associated phospholipase-A2 (Lp-PLA2) as an inflammatory biomarker, was reported to be associated with cardiovascular events in patients with coronary heart disease. 39 Since inflammation is a key contributor to ACS, it may provide an explanation for the trend in our study that heterogeneous group had relatively high level of Lp-PLA2, although it was not statistically significant. The use of statins is currently thought to reduce cardiac mortality by a variety of mechanisms, including the inflammatory modulation properties of statins. 40 The EASY-FIT study reported that statin therapy showed an inverse correlation between the percentage change in macrophage grade and fibrous cap thickness, and the increase in fibrous cap thickness was associated with decrease in serum LDL-C. 24 Pathologically, infiltration and accumulation of macrophages is thought to be an essential process in the development of vulnerable plaques. 41 It weaken the structural integrity of the cap of atherosclerotic plaque and predispose it to rupture. 42, 43 On multivariable logistic regression analysis, we found mean macrophage grade detected by OCT is an independent morphological risk factor of neointimal heterogeneity.
Taguchi et al reported that OCT-macrophage accumulation was associated with diabetes mellitus in patients with coronary artery disease. 44 Another study has demonstrated that patients with DM had a higher prevalence of lipid-rich plaque and macrophage accumulation at the culprit plaques. 45 Our study may lead to a better understanding of the association between plaque inflammation and plaque vulnerability.
Neoatherosclerosis after DES implantation was scarcely discovered in our study which may due to our short time interval between DES implantation and OCT follow-up. Time interval is believed to be strongly associated with neoatherosclerosis development. Although this interval is much lower than that for development of native atherosclerotic plaque, in vivo OCT studies showed an increasing of neoatherosclerosis at follow-up of up to 48 months after DES implantation. 46, 47 In addition, the possible overlap between pattern of neoatherosclerosis and heterogeneous or layered neointima may account for this phenomenon.
| Limitations
There are several limitations regarding this study. First, this is a singlecenter retrospective study with small sample size, which leads to small number of cases with neointimal heterogeneity and a lack of layered tissue data. Second, limited by its poor penetration, OCT could not visualize the entire plaque and its measurement of large luminal CSA is impaired. OCT cannot differentiate endothelialization from reendothelialization following stent uncoverage. Third, the definition of NIH is not quite clear and our study included only subjects with DEStreated lesions ≥100 μm of neointimal thickness. Fourth, we did quantitatively analysis at the CSA with the largest mean neointimal thickness rather than the whole stented segment at OCT follow-up assessment. Finally, there is a possibility of selection bias that may influence the results.
| CONCLUSIONS
This study has demonstrate that mean macrophage grade semiquantitatively measured by OCT as an morphological risk factor, as well as clinical presentation of ACS, is associated with in-stent heterogeneous neointimal hyperplasia after DES implantation. Further large scale studies are required to elucidate the relationship between plaque characteristics and subsequent pattern of in-stent hyperplasia.
